(MedPage Today) -- A dual-agonist compound that aims to boost two key gut hormones -- GLP-1 and GIP -- at the same time may offer better blood sugar control and weight loss than single-hormone drugs that are currently available, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment